ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

101–120 of 220 studies

Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.

Prins, J B, Bleijenberg, G, Bazelmans, E et al.·Lancet (London, England)·2001

This study tested whether cognitive behaviour therapy (CBT)—a type of talking therapy that focuses on thoughts and behaviours—helps people with ME/CFS. Researchers compared CBT with support groups and no treatment across three hospitals, following 278 patients for 14 months. CBT showed modest benefits for fatigue and daily functioning compared to the other groups, though only about one-third to one-half of patients experienced meaningful improvement.

Evidence Atlas

Evidence browser

Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.

A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.

Illness beliefs and treatment outcome in chronic fatigue syndrome.

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.

Hyperbaric oxygen therapy improves clinical symptoms and functional capacity and modulates thalamic connectivity in ME/CFS: a prospective cohort study.

Association between light exposure patterns and multidimensional health outcomes in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: findings from an observational cross-sectional cohort study.

Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluation.

Association of rapamycin treatment with the modulation of purine metabolism, reduced microglial inflammatory responses, improved mitochondrial energy metabolism, and alleviation of fatigue symptoms in ME/CFS subjects: pilot findings from phase-II observational study.

Exploratory clinical and immunological changes following Tixagevimab/Cilgavimab administration in immunodeficient patients with SARS-CoV-2-associated ME/CFS and persistent circulating spike protein.

Evaluation of an Integrated Multidisciplinary Care Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Open-label, Non-randomized Controlled Intervention Study.

Testing a Personalised Dysautonomia Management Protocol in Patients with Orthostatic Intolerance and a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Long COVID.

Use and Perceived Helpfulness of Different Intervention Strategies in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression.

Medication use and symptomology in North American women with myalgic encephalomyelitis/chronic fatigue syndrome.

Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.

Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey.

Robuvit® reduces fatigue after chemotherapy for colon cancer. A pilot registry study.

The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome.

Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research